Publication

CD4<sup>+</sup>Foxp3<sup>+</sup> T cells promote aberrant immunoglobulin G production and maintain CD8<sup>+</sup> T-cell suppression during chronic liver disease

Downloadable Content

Persistent URL
Last modified
  • 03/14/2025
Type of Material
Authors
    Dana Tedesco, Emory UniversityManoj Thapa, Emory UniversitySanjeev Gumber, Emory UniversityElizabeth J. Elrod, Emory UniversityKhalidur Rahman, Emory UniversityChris Ibegbu, Emory UniversityJoseph F. Magliocca, Emory UniversityAndrew Adams, Emory UniversityFrank A Anania, Emory UniversityArash Grakoui, Emory University
Language
  • English
Date
  • 2017-02-01
Publisher
  • Wiley: 12 months
Publication Version
Copyright Statement
  • © 2016 by the American Association for the Study of Liver Diseases
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 0270-9139
Volume
  • 65
Issue
  • 2
Start Page
  • 661
End Page
  • 677
Grant/Funding Information
  • Immunology and Flow Cytometry Core of the Center for AIDS Research at Emory University. Grant Number: P30AI050409
  • Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.
  • National Institutes of Health. Grant Numbers: R01AI070101, R01AI124680, R01AI126890, R01 DK062092, VA I01BX001746, ORIP/OD P51OD011132
  • National Institute of Diabetes, Digestive and Kidney Diseases. Grant Number: F32DK101163
Supplemental Material (URL)
Abstract
  • Persistent hepatotropic viral infections are a common etiologic agent of chronic liver disease. Unresolved infection can be attributed to nonfunctional intrahepatic CD8+ T-cell responses. In light of dampened CD8 + T-cell responses, liver disease often manifests systemically as immunoglobulin (Ig)-related syndromes due to aberrant B-cell functions. These two opposing yet coexisting phenomena implicate the potential of altered CD4 + T-cell help. Elevated CD4 + forkhead box P3–positive (Foxp3+) T cells were evident in both human liver disease and a mouse model of chemically induced liver injury despite marked activation and spontaneous IgG production by intrahepatic B cells. While this population suppressed CD8 + T-cell responses, aberrant B-cell activities were maintained due to expression of CD40 ligand on a subset of CD4 + Foxp3+ T cells. In vivo blockade of CD40 ligand attenuated B-cell abnormalities in a mouse model of liver injury. A phenotypically similar population of CD4 + Foxp3+, CD40 ligand–positive T cells was found in diseased livers explanted from patients with chronic hepatitis C infection. This population was absent in nondiseased liver tissues and peripheral blood. Conclusion: Liver disease elicits alterations in the intrahepatic CD4 + T-cell compartment that suppress T-cell immunity while concomitantly promoting aberrant IgG mediated manifestations. (Hepatology 2017;65:661-677).
Author Notes
  • Corresponding Author: Arash Grakoui, Division of Infectious diseases, Emory Vaccine Center, Division of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322, Telephone: (404) 727-5850; Fax: (404) 727-7768; arash.grakoui@emory.edu
Keywords
Research Categories
  • Biology, Microbiology
  • Health Sciences, Immunology

Tools

Relations

In Collection:

Items